Medirom Healthcare Technologies Stock Market Value
| MRM Stock | USD 1.09 0.03 2.68% |
| Symbol | Medirom |
Medirom Healthcare Price To Book Ratio
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.582 | Earnings Share (0.15) | Revenue Per Share 1.4 K | Quarterly Revenue Growth (0.06) | Return On Assets (0.04) |
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Medirom Healthcare 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medirom Healthcare's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medirom Healthcare.
| 07/01/2024 |
| 12/28/2024 |
If you would invest 0.00 in Medirom Healthcare on July 1, 2024 and sell it all today you would earn a total of 0.00 from holding Medirom Healthcare Technologies or generate 0.0% return on investment in Medirom Healthcare over 180 days. Medirom Healthcare is related to or competes with HR Block, Service International, Rollins, WW International, and Carriage Services. MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan More
Medirom Healthcare Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medirom Healthcare's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medirom Healthcare Technologies upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 78.45 | |||
| Value At Risk | (13.61) | |||
| Potential Upside | 11.87 |
Medirom Healthcare Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medirom Healthcare's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medirom Healthcare's standard deviation. In reality, there are many statistical measures that can use Medirom Healthcare historical prices to predict the future Medirom Healthcare's volatility.| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (1.39) | |||
| Total Risk Alpha | (1.58) | |||
| Treynor Ratio | (0.36) |
Medirom Healthcare Backtested Returns
Medirom Healthcare has Sharpe Ratio of -0.11, which conveys that the firm had a -0.11% return per unit of risk over the last 3 months. Medirom Healthcare exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Medirom Healthcare's Risk Adjusted Performance of (0.1), standard deviation of 9.7, and Mean Deviation of 6.13 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 3.68, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Medirom Healthcare will likely underperform. At this point, Medirom Healthcare has a negative expected return of -1.08%. Please make sure to verify Medirom Healthcare's treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Medirom Healthcare performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.07 |
Virtually no predictability
Medirom Healthcare Technologies has virtually no predictability. Overlapping area represents the amount of predictability between Medirom Healthcare time series from 1st of July 2024 to 29th of September 2024 and 29th of September 2024 to 28th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medirom Healthcare price movement. The serial correlation of 0.07 indicates that barely 7.0% of current Medirom Healthcare price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.07 | |
| Spearman Rank Test | -0.14 | |
| Residual Average | 0.0 | |
| Price Variance | 0.54 |
Medirom Healthcare lagged returns against current returns
Autocorrelation, which is Medirom Healthcare stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Medirom Healthcare's stock expected returns. We can calculate the autocorrelation of Medirom Healthcare returns to help us make a trade decision. For example, suppose you find that Medirom Healthcare has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Medirom Healthcare regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Medirom Healthcare stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Medirom Healthcare stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Medirom Healthcare stock over time.
Current vs Lagged Prices |
| Timeline |
Medirom Healthcare Lagged Returns
When evaluating Medirom Healthcare's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Medirom Healthcare stock have on its future price. Medirom Healthcare autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Medirom Healthcare autocorrelation shows the relationship between Medirom Healthcare stock current value and its past values and can show if there is a momentum factor associated with investing in Medirom Healthcare Technologies.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Medirom Healthcare Correlation, Medirom Healthcare Volatility and Medirom Healthcare Alpha and Beta module to complement your research on Medirom Healthcare. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Medirom Healthcare technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.